PLRX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $1.03

Kapitalisasi Pasar (MRQ) $64M

P/E -0.4

EPS $-2.43

Pendapatan $0

ROE -74.4%

Rentang 52M $1–$2

PLRX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang Pliant Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Wikidata ↗

sektorHealthcare industriPharmaceuticals karyawan49 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$0

2019-12-31 → 2025-12-31

EPS$-2.43

2019-12-31 → 2025-12-31

Arus Kas Bebas$-129M

2020-12-31 → 2025-12-31

Margin bersih·

2020-12-31 → 2023-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	PLRX	rata-rata 5T	Median Rekan	Kesimpulan
P/E	-0.4rata-rata 5T ≈-4.5	≈-4.5	·	·
P/B (MRQ)	0.4rata-rata 5T ≈2.1	≈2.1	3.9	Kurang nilai
Harga / FCF (TTM)	-0.9rata-rata 5T ≈-6.2	≈-6.2	·	·
Harga / Arus Kas (TTM)	-0.9rata-rata 5T ≈-6.3	≈-6.3	·	·
Price / Tangible Book (Harga / Nilai Buku Berwujud)	0.4rata-rata 5T ≈2.1	≈2.1	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	Tren 5 Tahun	PLRX	rata-rata 5T	Median Rekan	Kesimpulan
ROA		-48.0%rata-rata 5T ≈-43.7%	≈-43.7%	-53.7%	Sejajar
ROE		-74.4%rata-rata 5T ≈-52.5%	≈-52.5%	-120.8%	Tingkat teratas

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	Tren 5 Tahun	PLRX	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)		9.9rata-rata 5T ≈13.7	≈13.7	4.3	Likuiditas kuat
Quick Ratio (Rasio Cepat)		11.7rata-rata 5T ≈13.4	≈13.4	4.1	Likuiditas kuat

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	Tren 5 Tahun	PLRX	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)		-83.7%rata-rata 5T ≈-45.9%	≈-45.9%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)		-66.4%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	PLRX	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-2.43rata-rata 5T ≈$-2.86	≈$-2.86	·	·
Revenue / Share (Pendapatan / Saham)	$0.00rata-rata 5T ≈$0.06	≈$0.06	·	·
Cash Flow / Share (Arus Kas / Saham)	$-2.09rata-rata 5T ≈$-2.22	≈$-2.22	·	·
Cash / Share (Kas / Saham)	$0.74rata-rata 5T ≈$0.91	≈$0.91	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	Tren 5 Tahun	PLRX	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)		0.0rata-rata 5T ≈0.0	≈0.0	0.0	Lemah
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)		≈$0.00	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 0.86%

Laporan Berikutnya Nov 04, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Agu 5, 2026	$-0.36	$-0.35	-3.2%
31 Maret 2026	Mei 6, 2026	$-0.32	$-0.36	12.0%
31 Des. 2025		$-0.38	$-0.39	1.5%
30 Sep. 2025		$-0.43	$-0.53	19.5%
30 Juni 2025		$-0.71	$-0.71	-0.10%
31 Maret 2025		$-0.92	$-0.74	-24.5%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 15

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$0	$0	$2M	$10M	$8M	$42M	$57M
R&D Expense	$109M	$169M	$128M	$97M	$78M	$66M	$47M
SG&A Expense	$47M	$59M	$58M	$40M	$28M	$17M	$11M
Operating Expenses	$156M	$228M	$186M	$137M	$105M	$83M	$58M
Operating Income	$-156M	$-228M	$-184M	$-127M	$-98M	$-42M	$-1M
Interest Expense	·	·	$1M	$791.0K	$0	·	·
Interest Income	·	·	·	·	·	$478.0K	$816.0K
Other Non-op	·	·	·	·	·	$-366.0K	$-216.0K
Income Tax	$0	$0	$0	$0	$0	$0	$0
Net Income	$-149M	$-210M	$-161M	$-123M	$-97M	$-42M	$-631.0K
EPS (Basic)	$-2.43	$-3.47	$-2.75	$-2.94	$-2.71	$-1.95	$-4.22
EPS (Diluted)	$-2.43	$-3.47	$-2.75	$-2.94	$-2.71	$-1.95	$-4.22
Shares (Basic)	61,366,887	60,538,639	58,719,083	42,015,908	35,846,421	21,344,236	1,623,358
Shares (Diluted)	61,366,887	60,538,639	58,719,083	42,015,908	35,846,421	21,344,236	1,623,358
EBITDA	$-156M	$-228M	$-184M	$-127M	·	$-42M	·

Neraca 23

Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$45M	$71M	$63M	$34M	$52M	$51M	$86M
Short-term Investments	$145M	$285M	$431M	$298M	$149M	$226M	$17M
Receivables	·	·	$0	$2M	$2M	$9M	$7M
Prepaid Expense	$4M	$7M	$11M	$7M	$7M	$4M	$2M
Current Assets	$196M	$362M	$506M	$340M	$209M	$291M	$112M
PP&E (Net)	$3M	$6M	$4M	$4M	$5M	$4M	$4M
PP&E (Gross)	$14M	$16M	$12M	$11M	$10M	$8M	$6M
Accum. Depreciation	$11M	$11M	$9M	$7M	$5M	$3M	$2M
Other Non-current Assets	$392.0K	$435.0K	$392.0K	$394.0K	$838.0K	$451.0K	$3M
Total Assets	$225M	$397M	$512M	$351M	$221M	$296M	$119M
Accounts Payable	$480.0K	$6M	$5M	$2M	$3M	$2M	$1M
Accrued Liabilities	$10M	$12M	$10M	$9M	$12M	$10M	$7M
Current Liabilities	$16M	$33M	$29M	$24M	$17M	$12M	$8M
Capital Leases	$28M	$29M	$0	$3M	$5M	$0	·
Other Non-current Liabilities	·	·	·	·	$0	$866.0K	$912.0K
Total Liabilities	$44M	$93M	$39M	$37M	$22M	$12M	$9M
Long-term Debt	$0	$30M	$10M	$10M	$0	·	·
Common Stock	$6.0K	$6.0K	$6.0K	$5.0K	$3.0K	$3.0K	$1.0K
Retained Earnings	$-859M	$-710M	$-500M	$-338M	$-215M	$-118M	$-76M
AOCI	$-15.0K	$321.0K	$345.0K	$-2M	$-201.0K	$-32.0K	$-1.0K
Stockholders' Equity	$181M	$304M	$474M	$313M	$199M	$283M	$-76M
Liabilities + Equity	$225M	$397M	$512M	$351M	$221M	$296M	$119M
Shares Outstanding	61,449,290	60,860,838	59,921,002	48,941,254	36,083,301	35,552,795	1,846,024

Arus Kas 8

Metrik	2025	2024	2023	2022	2021	2020	2019
Stock-based Comp	$26M	$38M	$44M	$23M	$10M	$4M	$2M
Operating Cash Flow	$-128M	$-156M	$-116M	$-95M	$-75M	$-37M	$-3M
CapEx	$374.0K	$4M	$921.0K	$2M	$2M	$2M	$964.0K
Investing Cash Flow	$134M	$140M	$-127M	$-150M	$74M	$-211M	$-18M
Financing Cash Flow	$-32M	$23M	$274M	$227M	$3M	$213M	$46M
Net Change in Cash	$-26M	$8M	$31M	$-18M	$783.0K	$-35M	$25M
Taxes Paid	$0	$0	·	·	·	·	·
Free Cash Flow	$-129M	$-159M	$-117M	$-96M	·	$-39M	·

Profitabilitas 5

Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	·	·	-11654.8%	-1313.4%	·	-99.6%	·
Net Margin	·	·	-10211.1%	-1273.3%	·	-99.3%	·
EBITDA Margin	·	·	-11654.8%	-1313.4%	·	-99.6%	·
ROA	-48.0%	-46.3%	-37.4%	-43.1%	·	-20.0%	·
ROE	-74.4%	-64.7%	-33.0%	-37.9%	·	-14.2%	·

Likuiditas & Solvabilitas 3

Metrik	2025	2024	2023	2022	2021	2020	2019
Current Ratio	12.0	10.9	17.7	14.2	·	25.1	·
Quick Ratio	11.7	10.7	17.3	13.9	·	24.7	·
Interest Coverage	·	·	-145.3	·	·	·	·

Efisiensi 2

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.0	0.0	0.0	0.0	·	0.2	·
Receivables Turnover		·	·	1.6	4.9	·	5.1	·

Per Saham 7

Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$2.95	$5.00	$7.90	$6.40	·	$7.96	·
Revenue / Share	$0.00	$0.00	$0.03	$0.23	·	$1.96	·
Cash Flow / Share	$-2.09	$-2.57	$-1.98	$-2.25	·	$-1.75	·
Cash / Share	$0.74	$1.17	$1.06	$0.69	·	$1.43	·
Dividend / Share	$0.00	$0.00	$0.00	$0.00	·	$0.00	·
Dividend Paid / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	·
EPS (TTM)	$-2.43	$-3.47	$-2.75	$-2.94	$-2.71	$-1.95	·

Tingkat Pertumbuhan 2

Metrik	Tren	2025	2024	2023	2022	2021	2020	2019
Revenue YoY		·	·	-83.7%	27.9%	-81.9%	·	·
Revenue CAGR 3Y		·	·	-66.4%	·	·	·	·

Valuasi (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$0	$0	$2M	$10M	$8M	$42M	·
Net Income TTM	$-149M	$-210M	$-161M	$-123M	$-97M	$-42M	·
Market Cap	$75M	$802M	$1.09B	$946M	·	$808M	·
P/E	-0.5	-3.8	-6.6	-6.6	-5.0	-11.7	·
P/S	·	·	686.8	97.7	·	19.3	·
P/B	0.4	2.6	2.3	3.0	·	2.9	·
P / Tangible Book	0.4	2.6	2.3	3.0	·	2.9	·
P / Cash Flow	-0.6	-5.2	-9.3	-10.0	·	-21.7	·
P / FCF	-0.6	-5.0	-9.3	-9.8	·	-20.8	·
Earnings Yield	-199.2%	-26.4%	-15.2%	-15.2%	-20.1%	-8.6%	·

Laporan Laba Rugi 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0	$248.0K	$1M	$1M	$5M
R&D Expense	$17M	$14M	$16M	$18M	$32M	$43M	$39M	$48M	$46M	$37M	$33M	$32M	$33M	$29M	$25M	$26M
SG&A Expense	$7M	$8M	$8M	$10M	$13M	$15M	$15M	$14M	$15M	$15M	$14M	$15M	$15M	$14M	$9M	$8M
Operating Expenses	$24M	$22M	$24M	$28M	$46M	$59M	$53M	$62M	$61M	$52M	$47M	$48M	$48M	$43M	$33M	$35M
Operating Income	$-24M	$-22M	$-24M	$-28M	$-46M	$-59M	$-53M	$-62M	$-61M	$-52M	$-47M	$-48M	$-47M	$-42M	$-32M	$-30M
Interest Expense	·	·	·	·	·	·	·	·	·	$445.0K	·	$317.0K	$319.0K	$311.0K	$301.0K	$173.0K
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$-22M	$-20M	$-24M	$-26M	$-43M	$-56M	$-50M	$-58M	$-56M	$-47M	$-41M	$-41M	$-41M	$-38M	$-31M	$-30M
EPS (Basic)	$-0.36	$-0.32	$-0.37	$-0.43	$-0.71	$-0.92	$-0.82	$-0.95	$-0.92	$-0.78	$-0.68	$-0.70	$-0.70	$-0.67	$-0.65	$-0.82
EPS (Diluted)	$-0.36	$-0.32	$-0.37	$-0.43	$-0.71	$-0.92	$-0.82	$-0.95	$-0.92	$-0.78	$-0.68	$-0.70	$-0.70	$-0.67	$-0.65	$-0.82
Shares (Basic)	61,919,233	61,803,467	·	61,406,475	61,386,183	61,222,676	·	60,730,935	60,382,796	60,180,921	·	59,688,451	59,172,869	56,057,603	46,799,058	36,173,135
Shares (Diluted)	61,919,233	61,803,467	·	61,406,475	61,386,183	61,222,676	·	60,730,935	60,382,796	60,180,921	·	59,688,451	59,172,869	56,057,603	46,799,058	36,173,135
EBITDA	$-24M	$-22M	·	$-28M	$-46M	$-59M	·	$-62M	$-61M	$-52M	·	$-48M	$-47M	$-42M	$-32M	$-30M

Neraca 22

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Cash & Equivalents	$25M	$22M	$45M	$94M	$87M	$92M	$71M	$80M	$80M	$114M	$63M	$58M	$55M	$103M	$45M	$25M
Short-term Investments	$133M	$149M	$145M	$148M	$176M	$214M	$285M	$325M	$356M	$368M	$431M	$466M	$500M	$475M	$316M	$139M
Receivables	·	·	·	·	·	·	·	·	·	·	·	$0	$2M	$3M	$1M	$5M
Prepaid Expense	$4M	$3M	$4M	$4M	$5M	$6M	$7M	$6M	$11M	$8M	$11M	$11M	$9M	$8M	$4M	$5M
Current Assets	$163M	$175M	$196M	$246M	$267M	$311M	$362M	$410M	$448M	$490M	$506M	$534M	$566M	$588M	$366M	$174M
PP&E (Net)	$2M	$3M	$3M	$4M	$5M	$5M	$6M	$6M	$5M	$6M	$4M	$4M	$4M	$4M	$5M	$5M
PP&E (Gross)	$13M	$13M	$14M	$16M	$17M	$16M	$16M	$16M	$15M	$15M	$12M	$12M	$12M	$11M	$11M	$10M
Accum. Depreciation	$11M	$10M	$11M	$12M	$12M	$11M	$11M	$10M	$10M	$9M	$9M	$8M	$8M	$7M	$6M	$6M
Other Non-current Assets	$554.0K	$389.0K	$392.0K	$392.0K	$391.0K	$427.0K	$435.0K	$427.0K	$437.0K	$392.0K	$392.0K	$392.0K	$672.0K	$644.0K	$397.0K	$913.0K
Total Assets	$190M	$203M	$225M	$277M	$300M	$345M	$397M	$446M	$484M	$522M	$512M	$540M	$575M	$598M	$377M	$185M
Accounts Payable	$2M	$362.0K	$480.0K	$485.0K	$1M	$6M	$6M	$7M	$3M	$7M	$5M	$3M	$2M	$1M	$3M	$3M
Accrued Liabilities	$4M	$4M	$10M	$8M	$7M	$7M	$12M	$10M	$8M	$6M	$10M	$8M	$7M	·	$20M	$17M
Current Liabilities	$16M	$10M	$16M	$18M	$21M	$28M	$33M	$40M	$31M	$30M	$29M	$27M	$30M	$23M	$26M	$23M
Capital Leases	$26M	$27M	$28M	$28M	$29M	$29M	$29M	$30M	$30M	$24M	$0	$0	$2M	$3M	$4M	$4M
Total Liabilities	$43M	$37M	$44M	$76M	$80M	$88M	$93M	$100M	$91M	$84M	$39M	$37M	$42M	$36M	$40M	$37M
Long-term Debt	$0	$0	$0	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$10M	$10M	$10M	$10M	$10M	$10M
Common Stock	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$6.0K	$5.0K	$3.0K
Retained Earnings	$-902M	$-879M	$-859M	$-836M	$-810M	$-766M	$-710M	$-660M	$-603M	$-547M	$-500M	$-459M	$-417M	$-376M	$-303M	$-273M
AOCI	$-397.0K	$-341.0K	$-15.0K	$34.0K	$-1.0K	$159.0K	$321.0K	$848.0K	$-617.0K	$-489.0K	$345.0K	$-2M	$-2M	$-1M	$-2M	$-1M
Stockholders' Equity	$147M	$165M	$181M	$200M	$220M	$257M	$304M	$346M	$393M	$437M	$474M	$503M	$533M	$562M	$337M	$148M
Liabilities + Equity	$190M	$203M	$225M	$277M	$300M	$345M	$397M	$446M	$484M	$522M	$512M	$540M	$575M	$598M	$377M	$185M
Shares Outstanding	61,920,154	61,914,569	61,449,290	61,449,290	61,386,183	61,386,183	60,860,838	60,849,503	60,425,144	60,318,542	59,921,002	59,890,980	59,222,685	58,978,902	48,749,842	36,182,297

Arus Kas 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Stock-based Comp	$4M	$4M	$5M	$6M	$6M	$9M	$8M	$9M	$11M	$10M	$9M	$10M	$13M	$12M	$5M	$3M
Operating Cash Flow	$-13M	$-19M	$-18M	$-21M	$-41M	$-49M	$-48M	$-32M	$-45M	$-30M	$-25M	$-36M	$-25M	$-30M	$-18M	$-24M
CapEx	$0	$0	$0	$0	$112.0K	$262.0K	$209.0K	$896.0K	$1M	$1M	$61.0K	$94.0K	$603.0K	$163.0K	$696.0K	$254.0K
Investing Cash Flow	$15M	$-4M	$2M	$28M	$35M	$69M	$39M	$31M	$11M	$60M	$32M	$38M	$-23M	$-174M	$-178M	$6M
Financing Cash Flow	$0	$74.0K	$-32M	$72.0K	$0	$498.0K	$102.0K	$543.0K	$684.0K	$22M	$219.0K	$699.0K	$161.0K	$273M	$216M	$10M
Net Change in Cash	$3M	$-23M	$-48M	$7M	$-5M	$21M	$-8M	$-770.0K	$-34M	$51M	$7M	$3M	$-48M	$69M	$20M	$-7M
Free Cash Flow	·	$-19M	·	·	·	$-49M	·	·	·	$-32M	·	·	·	$-30M	·	·

Profitabilitas 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Operating Margin	·	·	·	·	·	·	·	·	·	·	·	·	-19083.9%	-3160.3%	-2155.7%	-594.1%
Net Margin	·	·	·	·	·	·	·	·	·	·	·	·	-16609.7%	-2818.9%	-2065.8%	-592.2%
EBITDA Margin	·	·	·	·	·	·	·	·	·	·	·	·	-19083.9%	-3160.3%	-2155.7%	-594.1%
ROA	-9.1%	-7.3%	·	-7.3%	-11.1%	-13.0%	·	-11.7%	-10.5%	-8.4%	·	-9.0%	-10.8%	-9.4%	-10.0%	-13.4%
ROE	-12.2%	-9.5%	·	-9.6%	-14.1%	-16.2%	·	-13.6%	-12.1%	-9.4%	·	-9.9%	-12.1%	-10.2%	-11.0%	-15.1%

Likuiditas & Solvabilitas 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Current Ratio	9.9	16.9	·	13.9	13.0	11.0	·	10.3	14.5	16.1	·	19.5	19.2	25.4	14.0	7.7
Quick Ratio	9.6	16.5	·	13.7	12.8	10.8	·	10.1	14.1	15.9	·	19.1	18.9	25.1	13.8	7.5
Interest Coverage	·	·	·	·	·	·	·	·	·	-117.7	·	-150.4	-148.4	-135.4	·	·

Efisiensi 2

Metrik	Tren	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Asset Turnover		·	·	·	·	·	·	·	0.0	0.0	0.0	·	0.0	0.0	0.0	0.0	0.0
Receivables Turnover		·	·	·	·	·	·	·	·	·	·	·	0.0	0.1	0.6	1.0	1.5

Per Saham 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Book Value / Share	$2.37	$2.67	·	$3.26	$3.59	$4.19	·	$5.68	$6.50	$7.25	·	$8.40	$9.00	$9.53	$6.91	$4.08
Revenue / Share	·	·	·	·	·	·	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.02	$0.03	$0.14
Cash Flow / Share	·	$-0.31	·	·	·	$-0.80	·	·	·	$-0.50	·	·	·	$-0.54	·	·
Cash / Share	$0.40	$0.36	·	$1.53	$1.41	$1.50	·	$1.31	$1.33	$1.89	·	$0.96	$0.93	$1.74	$0.92	$0.69
Dividend / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
Dividend Paid / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
EPS (TTM)	$-1.48	$-1.83	·	$-2.88	$-3.40	$-3.61	·	$-3.33	$-3.08	$-2.86	·	$-2.76	$-2.71	$-2.83	$-2.93	$-3.03

Valuasi (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue TTM	$0	$0	·	$0	$0	$0	·	$0	$0	$248.0K	·	$4M	$5M	$10M	$10M	$10M
Net Income TTM	$-92M	$-113M	·	$-175M	$-207M	$-220M	·	$-202M	$-185M	$-171M	·	$-155M	$-144M	$-133M	$-113M	$-109M
Market Cap	$71M	$78M	·	$91M	$71M	$83M	·	$682M	$650M	$899M	·	$1.04B	$1.07B	$1.57B	$1.02B	$290M
P/E	-0.8	-0.7	·	-0.5	-0.3	-0.4	·	-3.4	-3.5	-5.2	·	-6.3	-6.7	-9.4	-7.1	-2.6
P/S	·	·	·	·	·	·	·	·	·	3624.0	·	293.0	213.5	160.6	104.8	29.4
P/B	0.5	0.5	·	0.5	0.3	0.3	·	2.0	1.7	2.1	·	2.1	2.0	2.8	3.0	2.0
P / Tangible Book	0.5	0.5	·	0.5	0.3	0.3	·	2.0	1.7	2.1	·	2.1	2.0	2.8	3.0	2.0
P / Cash Flow	·	-4.1	·	·	·	-1.7	·	·	·	-29.7	·	·	·	-51.8	·	·
Earnings Yield	-129.8%	-145.2%	·	-194.6%	-293.1%	-267.4%	·	-29.7%	-28.6%	-19.2%	·	-15.9%	-15.0%	-10.6%	-14.0%	-37.8%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$0	$0	$2M	$10M	$8M
Margin Operasi %	·	·	-11654.8%	-1313.4%	·
Laba Bersih	$-149M	$-210M	$-161M	$-123M	$-97M
EPS Dilusian	$-2.43	$-3.47	$-2.75	$-2.94	$-2.71

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rasio Lancar	12.0	10.9	17.7	14.2	·
Rasio Cepat	11.7	10.7	17.3	13.9	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$-129M	$-159M	$-117M	$-96M	·

Pemilik institusional (13F) 99 pengaju · $56.9M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 99

Nilai yang dipegang $56.9M

Posisi baru 12

Posisi yang keluar 12

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
12 (-2 vs Kuartal sebelumnya)	12 (-1 vs Kuartal sebelumnya)	18 (-8 vs Kuartal sebelumnya)	27 (0 vs Kuartal sebelumnya)	-1.3M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
TANG CAPITAL MANAGEMENT LLC	$7.001.038	6.141.261	12,30%	Saham
ADAR1 Capital Management, LLC	$6.281.085	5.509.724	11,04%	Saham
VANGUARD GROUP INC	$3.438.255	2.818.241	6,04%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$2.782.000	2.440.351	4,89%	Saham
TWO SIGMA INVESTMENTS, LP	$2.579.628	2.262.832	4,53%	Saham
CITADEL ADVISORS LLC	$2.442.138	2.142.226	4,29%	Saham
RENAISSANCE TECHNOLOGIES LLC	$2.336.856	2.049.874	4,11%	Saham
Monaco Asset Management SAM	$2.210.172	1.938.747	3,88%	Saham
Lynx1 Capital Management LP	$2.049.800	1.798.070	3,60%	Saham
BML Capital Management, LLC	$1.762.596	1.546.137	3,10%	Saham
Prosight Management, LP	$1.562.066	1.370.233	2,74%	Saham
TWO SIGMA ADVISERS, LP	$1.519.632	1.245.600	2,67%	Saham
Peapod Lane Capital LLC	$1.492.275	1.309.013	2,62%	Saham
Woodline Partners LP	$1.478.049	1.296.534	2,60%	Saham
BlackRock, Inc.	$1.312.384	1.151.214	2,31%	Saham
Ikarian Capital, LLC	$1.140.000	1.000.000	2,00%	Saham
Eversept Partners, LP	$1.016.224	891.425	1,79%	Saham
MARSHALL WACE, LLP	$952.041	835.124	1,67%	Saham
Redmile Group, LLC	$880.224	772.126	1,55%	Saham
JPMORGAN CHASE & CO	$783.894	681.647	1,38%	Saham
JACOBS LEVY EQUITY MANAGEMENT, INC	$733.157	643.120	1,29%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$659.954	578.577	1,16%	Saham
UBS Group AG	$651.806	571.760	1,15%	Saham
MILLENNIUM MANAGEMENT LLC	$637.770	559.447	1,12%	Saham
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$631.138	553.630	1,11%	Saham
Connor, Clark & Lunn Investment Management Ltd.	$611.132	536.081	1,07%	Saham
DAFNA Capital Management LLC	$555.180	487.000	0,98%	Saham
XTX Topco Ltd	$502.562	440.844	0,88%	Saham
Laurion Capital Management LP	$470.587	412.796	0,83%	Saham
TORNO CAPITAL, LLC	$400.647	351.445	0,70%	Saham
VANGUARD FIDUCIARY TRUST CO	$389.596	341.751	0,68%	Saham
BOOTHBAY FUND MANAGEMENT, LLC	$345.420	303.000	0,61%	Saham
MORGAN STANLEY	$340.833	298.976	0,60%	Saham
SEI INVESTMENTS CO	$338.909	297.291	0,60%	Saham
Verdad Advisers, LP	$320.731	281.343	0,56%	Saham
ArrowMark Colorado Holdings LLC	$320.555	281.189	0,56%	Saham
NANO CAP NEW MILLENNIUM GROWTH FUND L P	$313.500	275.000	0,55%	Saham
STATE STREET CORP	$288.897	253.418	0,51%	Saham
Stonepine Capital Management, LLC	$262.813	230.538	0,46%	Saham
Rangeley Capital, LLC	$256.500	225.000	0,45%	Saham
GOLDMAN SACHS GROUP INC	$237.787	208.585	0,42%	Saham
Congress Wealth Management LLC / DE /	$231.907	199.920	0,41%	Saham
Marquette Asset Management, LLC	$198.930	174.500	0,35%	Saham
HighMark Wealth Management LLC	$189.495	166.224	0,33%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$175.232	153.712	0,31%	Saham
JANE STREET GROUP, LLC	$148.144	129.951	0,26%	Saham
NORTHERN TRUST CORP	$142.568	125.060	0,25%	Saham
ALGERT GLOBAL LLC	$140.678	123.402	0,25%	Saham
OSAIC HOLDINGS, INC.	$131.013	114.924	0,23%	Saham
Invesco Ltd.	$119.333	104.678	0,21%	Saham

Tampilkan semua 99 pemilik institusional →

Aktivis & pemilik 5%+ 1 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, TANG CAPITAL PARTNERS, LP, TANG CAPITAL PARTNERS INTERNATIONAL, LP, TANG CAPITAL PARTNERS III, INC, TANG CAPITAL PARTNERS IV, INC, CONCENTRA BIOSCIENCES, LLC	10 Maret 2025	9,60%	Pengajuan awal	Investasi pasif	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 23 orang dalam · 9 pejabat · 14 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Jual 12m	Bersih 12m
Bernard Coulie	President and CEO	17 April 2026 A	505.601	1	$-114.400
Keith Lamont Cummings	Chief Financial Officer	17 April 2026 A	297.214	1	$-30.723
Minnie Kuo	Chief Operating Officer	17 April 2026 A	37.806	1	$-8.854
David Raben	Chief Medical Officer	1 Okt. 2026 A	·	0	$0
Lily Cheung	Chief Human Resource Officer	17 April 2026 A	44.847	1	$-9.644
Mike Ouimette	General Counsel & Corp. Sec'y	23 Jan. 2025 A	105.544	0	$0
Hans Hull	Chief Business Officer	23 Jan. 2025 A	251.708	0	$0
Eric Lefebvre	Chief Medical Officer	23 Jan. 2025 A	240.224	0	$0
Barbara Howes	Chief Human Resource Officer	23 Jan. 2021 A	24.799	0	$0
Flavia Borellini	Direktur	9 Juli 2026 A	·	0	$0
Robert Iannone	Direktur	9 Juli 2026 A	·	0	$0
Steve E. Krognes	Direktur	11 Juni 2026 A	·	0	$0
Darren S Cline	Direktur	11 Juni 2026 A	·	0	$0
John T Curnutte	Direktur	11 Juni 2026 A	·	0	$0
Thomas A Mccourt	Direktur	11 Juni 2026 A	·	0	$0
Hoyoung Huh	Direktur	11 Juni 2026 A	239.619	0	$0
Gayle A Crowell	Direktur	11 Juni 2026 A	·	0	$0
Katharine Knobil	Direktur	5 Juni 2025 A	·	0	$0
Suzanne Louise Bruhn	Direktur	5 Juni 2025 A	·	0	$0
David E I Pyott	Direktur	5 Juni 2025 A	·	0	$0
Smital Shah	Direktur	13 Juni 2024 A	·	0	$0
Neil Exter	Direktur	16 Juni 2022 A	0	0	$0
Charles J Homcy	·	29 Juni 2021 A	·	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 5 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
IWC · iShares Trust	0,02%	205.246 SH	11 Sep. 2026	Harian
PRFZ · Invesco Exchange-Traded Fund Trust	0,00%	21.830 SH	2 Okt. 2026	Harian
VXF · VANGUARD INDEX FUNDS	0,00%	615.799 SH	19 Agu 2026	Harian
VTI · VANGUARD INDEX FUNDS	0,00%	1.746.470 SH	19 Agu 2026	Harian
VHT · VANGUARD WORLD FUND	0,00%	153.712 SH	19 Agu 2026	Harian

PLRX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 10 analis JUAL

Target median $2.00 +93,2%

0 0,0% Beli Kuat

0 0,0% Beli

6 60,0% Tahan

2 20,0% Jual

2 20,0% Jual Kuat

Target Harga 12 Bulan

1 analis · 2026-10-04

Target rata-rata $2.00 +93,2%

Rendah$2.00 Rata-rata$2.00 Tinggi$2.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
PLRX	$75M	-0.5	-83.7%	·	-74.4%	·
NTHI	·	-2.6	-51.8%	·	·	·
TELO	$46M	-4.0	·	·	-325.7%	·
VRCA	$143M	-4.9	370.2%	-50.3%	-492.8%	·
RFL	·	-1.6	44.0%	-3328.2%	-34.6%	·
CING	·	·	·	·	·	·
ELOX	·	·	·	·	30.1%	·
HYPD	$31M	-0.4	1318.8%	-5570.6%	-115.6%	62.7%
TLPH	$56M	·	·	-51035.7%	-120.8%	·

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

PLRX Pliant Therapeutics, Inc. - Common Stock